SHPH vs. HILS, KTTA, CLVR, VIRI, ATHE, SONN, ADXS, VCNX, AIMD, and XBIO
Should you be buying Shuttle Pharmaceuticals stock or one of its competitors? The main competitors of Shuttle Pharmaceuticals include Hillstream BioPharma (HILS), Pasithea Therapeutics (KTTA), Clever Leaves (CLVR), Virios Therapeutics (VIRI), Alterity Therapeutics (ATHE), Sonnet BioTherapeutics (SONN), Ayala Pharmaceuticals (ADXS), Vaccinex (VCNX), Ainos (AIMD), and Xenetic Biosciences (XBIO). These companies are all part of the "pharmaceutical preparations" industry.
Hillstream BioPharma (NASDAQ:HILS) and Shuttle Pharmaceuticals (NASDAQ:SHPH) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, community ranking, media sentiment, risk, analyst recommendations, valuation and institutional ownership.
13.4% of Hillstream BioPharma shares are owned by institutional investors. Comparatively, 4.6% of Shuttle Pharmaceuticals shares are owned by institutional investors. 30.2% of Hillstream BioPharma shares are owned by insiders. Comparatively, 40.6% of Shuttle Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Hillstream BioPharma received 1 more outperform votes than Shuttle Pharmaceuticals when rated by MarketBeat users.
Hillstream BioPharma's return on equity of -112.18% beat Shuttle Pharmaceuticals' return on equity.
In the previous week, Shuttle Pharmaceuticals had 5 more articles in the media than Hillstream BioPharma. MarketBeat recorded 6 mentions for Shuttle Pharmaceuticals and 1 mentions for Hillstream BioPharma. Shuttle Pharmaceuticals' average media sentiment score of 0.67 beat Hillstream BioPharma's score of 0.39 indicating that Hillstream BioPharma is being referred to more favorably in the media.
Hillstream BioPharma has a beta of 3.08, meaning that its share price is 208% more volatile than the S&P 500. Comparatively, Shuttle Pharmaceuticals has a beta of -1.17, meaning that its share price is 217% less volatile than the S&P 500.
Shuttle Pharmaceuticals is trading at a lower price-to-earnings ratio than Hillstream BioPharma, indicating that it is currently the more affordable of the two stocks.
Summary
Shuttle Pharmaceuticals beats Hillstream BioPharma on 6 of the 11 factors compared between the two stocks.
Get Shuttle Pharmaceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SHPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Shuttle Pharmaceuticals Competitors List
Related Companies and Tools